Please login to the form below

Not currently logged in
Email:
Password:

EULAR

This page shows the latest EULAR news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: EULAR kicks off, Brexit lurches closer and Autolus prepares for IPO

Daily Brief: EULAR kicks off, Brexit lurches closer and Autolus prepares for IPO

Today sees the European League Against Rheumatism (EULAR) congress kick off in Amsterdam, with all the big players presenting data over the next few days.

Latest news

More from news
Approximately 2 fully matching, plus 14 partially matching documents found.

Latest Intelligence

  • Case study: Immunology education Case study: Immunology education

    Sue Oliver, chair of the European League Against Rheumatism (EULAR) Healthcare Professionals Standing Committee said: “My personal experience as Arena Chair was a rewarding and exciting one.

  • Achieving remission Achieving remission

    Close collaboration with investor relations increased interest beyond medical media. •   ‘Realising the goal of remission’ media briefing held at EULAR 2009.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics